Review Cord Blood America
The first cord blood transplant was performed in 1988. Since then, more than 8,000 transplants have occurred.This Cord Blood can be collected only at birth, and if not taken these stem cells can not be replaced.This technology to collect and store newborn's umbilical cord blood stem cells has only been widely available since late 1995.Currently, thousands of parents are taking advantage of this once-in-a-lifetime opportunity. For regenerative medicine applications, the child's own cord blood is required.
It is recommended to preserve Cord Blood as a type of biological insurance as these stem cells can be a life saver at a later stage. Check out the complete list of dieseases cured by cord blood.Families recognize that their baby's cord blood may offer a lifetime of protection:
- The baby's cord blood may be used to treat nearly 80 diseases. Stem cells have been used for decades in lifesaving treatments for diseases including leukemia, other cancers, and blood disorders.
- Cord blood stem cells are showing significant potential to treat conditions that have no cure today - like juvenile diabetes and brain injury.
- The baby's cord blood is immediately available for the family if needed, and faster treatment is always better.
- For use in regenerative medicine therapies using cord blood, the child's own stem cells are required.
- For treating cancers and blood disorders in transplant medicine, having the family's own cord blood available may offer significant advantages if ever needed, including fewer complications, improved survival, and a better quality of life without the need for continual anti-rejection medications.
Some families have more defined risk factors, but most families bank for the security of knowing the health benefits that stem cells may someday offer their children, themselves, or other family members.
There had been lots of talk on the Cord Blood America which is currently traded in OTC.
Cord Blood America is a publically traded company and featured in countless news and media coverage.
CBAI, moving toward achieving its goal of becoming a globally dominant stem cell storage company, recently signed a deal licensing its umbilical cord blood technology to AXM Pharma Inc., a China pharmaceutical and nutraceutical company.
Cord Blood America is located at Las Vegas and currently is the largest cryogenic storage in the world. Readers must be aware of the Cryogenic technology used in rocket launchers.
Cryogenics is the freezing of live tissue or whole living organisms in order to defrost and bring them back to life at a later date. There are diseases that cannot be cured today and there is a theory about where some one may one day be kept on ice, while medical science works out how to cure the illness.
Information from Importance of Cord Blood Preservation
